Preoperative Chronic Opioid Therapy A Risk Factor for Complications, Readmission, Continued Opioid Use and Increased Costs After One- and Two-Level Posterior Lumbar Fusion

被引:126
|
作者
Jain, Nikhil [1 ]
Phillips, Frank M. [2 ]
Weaver, Tristan [1 ]
Khan, Safdar N. [1 ]
机构
[1] Ohio State Univ, Wexner Med Ctr, Columbus, OH 43210 USA
[2] Rush Univ, Med Ctr, Midwest Orthoped, Chicago, IL 60612 USA
关键词
adverse events; bundled payments; complications; cost; lumbar; narcotics; opioids; outcomes; reimbursement; spinal fusion; LOW-BACK-PAIN; DEGENERATIVE DISC DISEASE; LUMBAR FUSION; WORKERS-COMPENSATION; NARCOTIC USE; INDUCED HYPERALGESIA; SURGERY; DEPRESSION; OUTCOMES; DISABILITY;
D O I
10.1097/BRS.0000000000002609
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Study Design. Retrospective, economic analysis. Objective. To study patient profile associated with preoperative chronic opioid therapy (COT), and study COT as a risk factor for 90-day complications, emergency department (ED) visits, and readmission after primary one-to two-level posterior lumbar fusion (PLF) for degenerative spine disease. We also evaluated associated costs, risk factors, and adverse events related to long-term postoperative opioid use. Summary of Background Data. Chronic opioid use is associated with poor outcomes and dependence after spine surgery. Risk factors, complications, readmissions, adverse events, and costs associated with COT in patients undergoing lumbar fusion are not entirely known. As providers look to reduce healthcare costs and improve outcomes, identification of modifiable risk factors is important. Methods. Commercial insurance data from 2007 to Q3-2015 was used to study preoperative opioid use in patients undergoing primary one-to two-level PLF. Ninety-day complications, ED visits, readmissions, 1-year adverse events, and associated costs have been described. Multiple-variable regression analyses were done to study preoperative COT patient profile and opioid use as a risk factor for complications and adverse events. Results. A total of 24,610 patients with a mean age of 65.6 +/- 11.5 years were included. Five thousand five hundred (22.3%) patients had documented opioid use for more than 6 months before surgery, and 87.4% of these had continued long-term use postoperatively. On adjusted analysis, preoperative COT was found to be a risk factor for 90-day wound complications, pain diagnoses, ED visits, readmission, and continued use postoperatively. Postspinal fusion long-term opioid users had an increased utilization of epidural/facet joint injections, risk for revision fusion, and increased incidence of new onset constipation within 1 year postsurgery. The cost associated with increase resource use in these patients has been reported. Conclusion. Preoperative COT is a modifiable risk factor for complications, readmission, adverse events, and increased costs after one-or two-level PLF.
引用
收藏
页码:1331 / 1338
页数:8
相关论文
共 17 条
  • [1] Point of View Commentary on "Preoperative Chronic Opioid Therapy: a Risk Factor for Complications, Readmission, Continued Opioid Use and Increased Costs After One- and Two-level Posterior Lumbar Fusion''
    Deyo, Richard A.
    SPINE, 2018, 43 (19) : 1339 - 1339
  • [2] Chronic preoperative opioid use is a risk factor for increased complications, resource use, and costs after cervical fusion
    Jain, Nikhil
    Brock, John L.
    Phillips, Frank M.
    Weaver, Tristan
    Khan, Safdar N.
    SPINE JOURNAL, 2018, 18 (11): : 1989 - 1998
  • [3] The Effects of Chronic Preoperative Opioid Use on Single-level Lumbar Fusion Outcomes
    Bhattacharjee, Sarah
    Pirkle, Sean
    Shi, Lewis L.
    Lee, Michael J.
    CLINICAL SPINE SURGERY, 2020, 33 (08): : E401 - E406
  • [4] Enhanced Recovery After Surgery Protocols in One- or Two-Level Posterior Lumbar Fusion: Improving Postoperative Outcomes
    Choi, Ji Uk
    Kee, Tae-Hong
    Lee, Dong-Ho
    Hwang, Chang Ju
    Park, Sehan
    Cho, Jae Hwan
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (20)
  • [5] The Effect of Preoperative Exposure to Benzodiazepines on Opioid Consumption After One and Two-level Anterior Cervical Discectomy and Fusion
    Meade, Matthew H.
    Schultz, Matthew J.
    Radack, Tyler
    Michael, Mark
    Hilibrand, Alan S.
    Kurd, Mark F.
    Hsu, Victor
    Kaye, Ian David
    Schroeder, Gregory D.
    Kepler, Christopher
    Vaccaro, Alexander R.
    Woods, Barrett I.
    CLINICAL SPINE SURGERY, 2023, 36 (10): : E410 - E415
  • [6] Prediction of Complications, Readmission, and Revision Surgery Based on Duration of Preoperative Opioid Use Analysis of Major Joint Replacement and Lumbar Fusion
    Jain, Nikhil
    Brock, John L.
    Malik, Azeem Tariq
    Phillips, Frank M.
    Khan, Safdar N.
    JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2019, 101 (05): : 384 - 391
  • [7] Risk Factors for Continued Opioid Use One to Two Months After Surgery for Musculoskeletal Trauma
    Helmerhorst, Gijs T. T.
    Vranceanu, Ana-Maria
    Vrahas, Mark
    Smith, Malcolm
    Ring, David
    JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2014, 96A (06): : 495 - 499
  • [8] Preoperative Opioid Use Is a Risk Factor for Revision Surgery, Complications, and Increased Resource Utilization After Arthroscopic Rotator Cuff Repair
    Farley, Kevin X.
    Wilson, Jacob M.
    Spencer, Corey C.
    Karas, Spero
    Xerogeanes, John
    Gottschalk, Michael B.
    Wagner, Eric R.
    AMERICAN JOURNAL OF SPORTS MEDICINE, 2020, 48 (13): : 3339 - 3346
  • [9] The Effects of Liposomal Bupivacaine on Long-term Outcomes and Decreasing Immediate Postoperative Opioid Use Following One-level and Two-level Posterior Lumbar Fusions
    Gannon, Emmett
    Freeman, Matthew
    Cornett, Chris
    Vincent, Scott
    Powers, Sydney
    Lyden, Elizabeth
    CLINICAL SPINE SURGERY, 2023, 36 (01): : E29 - E34
  • [10] Lower Extremity Osteoarthritis: A Risk Factor for Mental Health Disorders, Prolonged Opioid Use, and Increased Resource Utilization After Single-Level Lumbar Spinal Fusion
    Turcotte, Justin J.
    King, Paul J.
    Patton, Chad M.
    JOURNAL OF THE AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS GLOBAL RESEARCH AND REVIEWS, 2022, 6 (03):